Skip to main content
Clinical Trials/NCT01561625
NCT01561625
Completed
Not Applicable

Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance

Laval University1 site in 1 country21 target enrollmentOctober 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Laval University
Enrollment
21
Locations
1
Primary Endpoint
Post-exercise signaling proteins phosphorylation level in the quadriceps of COPD patients and age-matched healthy controls
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Muscle weakness and atrophy are important consequences of chronic obstructive pulmonary disease (COPD). Although resistance exercises increase strength and muscle mass in patients with COPD, the response to training appears to be suboptimal in these individuals. A dysregulation in the signaling pathways involved in the regulation of muscle mass could play an important role in this phenomenon.

Hypothesis: Proteins involved in muscle mass regulation will be less activated in the quadriceps of patients with COPD following the acute bout of resistance training exercise compared to healthy age-matched controls.

Detailed Description

Our objective is to investigate the impact of an acute bout of resistance training on key signaling pathways involved in the regulation of muscle mass in moderate to severe COPD (FEV1 under 60% of predicted). Key proteins of signaling intramuscular pathways involved in protein synthesis and degradation will be measured before after 72 contractions of the quadriceps. The exercise protocol was designed to match the actual exercise prescription model use in the context of pulmonary rehabilitation. A squat, leg press and leg extension will be done at 80% of max with one minute rest between sets. A biopsy of the quadriceps will be done before and after exercise in order to measure phosphorylated kinases, total protein content and mRNA expressions. All our patients will undergo a thorough baseline assessment in pulmonary capacity, muscle force and body composition.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
April 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bruno Lemire

Étudiant au doctorat

Laval University

Eligibility Criteria

Inclusion Criteria

  • COPD with an FEV1 of under 60% of predicted
  • non-smoker
  • Between 50 and 75 years old

Exclusion Criteria

  • All inflammatory disease (HIV, Cancer, renal and cardiac deficiency)
  • Hormonal dysregulation
  • Inferior limb pathology
  • Neuromuscular pathology
  • History of tabacco or alcool abuse
  • Oxygen dependent
  • Recent exacerbation (2 months) of the symptoms of COPD

Outcomes

Primary Outcomes

Post-exercise signaling proteins phosphorylation level in the quadriceps of COPD patients and age-matched healthy controls

Time Frame: 2 hours post-exercise

Phosphorylation status of key proteins (Akt, p70, mTOR, p38, JNK, ERK) will be lesser modulated in the quadriceps of patients with COPD compare to healthy controls. The phosphorylated as well as the total protein levels will be measured by western blot. The data will be presented as arbitrary units and compared with values obtained in healthy age-matched healthy controls.

Study Sites (1)

Loading locations...

Similar Trials